CTKB — Cytek Biosciences Share News
0.000.00%
Last trade - 00:00- $703.21m
- $450.88m
- $201.49m
Cytek Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Cytek Biosciences Q3 Revenue USD 51.5 Million Vs. IBES Estimate USD 50.7 Million
Brief: Cytek Announces Resignation Of Chief Operating Officer Chris Williams
Brief: Cytek Biosciences Achieves ISO 13485 Certification At San Diego Reagent Manufacturing Facility
U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey
Cytek Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Cytek Biosciences Q2 Revenue USD 46.617 Million Vs. IBES Estimate USD 49.5 Million
Cytek Biosciences Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Cytek Biosciences Announces $50 Million Stock Repurchase Program
Brief: 1-Laser And 2-Laser 6-Color Tbnk Reagents From Cytek® Biosciences Approved For Clinical Use In China
Cytek Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cytek Biosciences Q1 Revenue USD 44.86 Million Vs. IBES Estimate USD 43.6 Million
Cytek Biosciences Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Highpeak Energy, Nordstrom, Victoria's Secret & Co
U.S. RESEARCH ROUNDUP-Arrivent Biopharma, Ferguson, Target
Brief: Cytek Biosciences Inc Files For Non- Timely 10-K With The U.S. SEC
Brief: Cytek Biosciences Q4 Revenue USD 58.6 Million Vs. IBES Estimate USD 56.6 Million
Cytek Biosciences Inc expected to post breakeven results a share - Earnings Preview
Brief: Cytek Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries